Navigation Links
Albert Einstein College of Medicine Receives $25-Million Gift to Support Stem Cell and Epigenomic Research and Clinical Skills Training
Date:5/13/2008

Gift is among largest in the College's history

BRONX, N.Y., May 13 /PRNewswire/ -- The Albert Einstein College of Medicine of Yeshiva University today announced that it has received a major gift of $25 million -- one of the largest in the College's 53-year history -- from Ruth L. and David S. Gottesman. A photo of the Gottesmans is available.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080513/NYTU059-a)

(Logo: http://www.newscom.com/cgi-bin/prnh/20080513/NYTU059LOGO-b)

The Gottesman gift will support several important research projects at the College of Medicine, most to be conducted in the new Michael F. Price Center for Genetic and Translational Medicine/Harold and Muriel Block Research Pavilion, which officially opens in June 2008. The Price Center/Block Research Pavilion is the largest medical research facility to be constructed in the Bronx since Einstein opened in 1955. A photo of the Price Center is available.

Funds from the gift will be allocated as follows: $15 million will be used to establish the Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research; $7 million will fund The Center for Epigenomics, to be headed by Einstein researcher Dr. John Greally; and $3 million will be used to create The Ruth L. Gottesman Clinical Skills Facility in the soon-to-be renovated Van Etten Building, which Einstein has leased from Jacobi Medical Center as part of its overall expansion. In addition, the gift will support an endowed chair at the Gottesman stem cell institute and a faculty scholar in Epigenomics, as well as the recruitment of top-flight faculty that will bolster Einstein's already prominent leadership in both of these important fields.

"In discussions with the College, we determined that stem cell
'/>"/>

SOURCE The Albert Einstein College of Medicine of YeshivaUniversity
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
2. Transplanted cells may hold the key to curing hemophilia A, Einstein scientists report
3. World Debut for BSPs HyperQ Stress System: 57th Annual American College of Cardiology Meeting 2008
4. Boston College, MIT researchers achieve dramatic increase in thermoelectric efficiency
5. CV Therapeutics Announces Presentations at the American College of Cardiology 57th Annual Scientific Session
6. CardioDynamics BioZ(R) ICG Technology Featured in American College of Cardiology (ACC) Audio Series
7. Logical Therapeutics Co-Founder and CEO Honored with a Distinguished Investigator Award from the American College of Critical Care Medicine
8. Results of Colon Cancer Study Utilizing Pressure Cycling Technology (PCT) Presented at the American College of Gastroenterology Annual Scientific Meeting
9. Trubion Pharmaceuticals Announces Upcoming Presentations at American College of Rheumatology Annual Scientific Meeting
10. KGI and Smith College Establish Leadership Forum for Women in Bioscience
11. Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118 (oral PEG-naloxol) at American College of Clinical Pharmacology Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... NEW ORLEANS , May 22, 2013 ... of regenerative medicine, presented new data generated in collaboration ... (a leading health economics consultancy) demonstrating the significant healthcare ... and venous leg ulcers (VLU) place upon the US ... research, which reveal annual costs of up to $15 ...
(Date:5/22/2013)... 2013 Express Diagnostics Int’l, Inc. ... are pleased to announce a sponsorship agreement with ... New Zealand distributor of DrugCheck® onsite testing devices, manufactured ... in the Austin 400 May 17-19 in Austin, Texas. ... that involves each car of the Erebus Motorsport team ...
(Date:5/22/2013)... 22, 2013  Moderna Therapeutics, the pioneering company developing ... enable the in vivo production of therapeutic ... will join Moderna in early July as its ... a proven leader in the design and implementation of ... discovery to translation, clinical operations and commercial preparedness. John ...
(Date:5/21/2013)... Through science fairs, workshops, kits for ... equipment, 25 organizations will continue their work to increase ... photonics in daily life with the aid of ... in 10 countries, are the first of two groups ... SPIE, the international society for optics and photonics , ...
Breaking Biology Technology:Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 2Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 3Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 4Australian Distributor of Express Diagnostics Signs Sponsorship Agreement with V8 Supercar Team 2Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer 2Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer 3Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 2Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 3
... ChanTest, the leading expert in ion channels and ... development, and safety -- is one of eight organizations ... and Commercialization Program. Governor Ted Strickland and Interim Director ... the Ohio Third Frontier Commission, Mark Barbash, announced the ...
... Aegera Therapeutics is pleased to announce the initiation ... AEG33773, a novel, orally bio-available small molecule therapeutic ... , The Phase 2a study, entitled A Multicenter, ... Efficacy of AEG33773 versus Placebo in Patients with ...
... May 6 iZumi Bio, Inc., a biotechnology ... stem cell (iPS) technology with the mission of ... differentiation of patient cells, today announced the appointments ... (CTO) and Dushyant Pathak, Ph.D., as vice president ...
Cached Biology Technology:ChanTest Awarded $4.8 Million Through the Ohio Third Frontier Research and Commercialization Program 2ChanTest Awarded $4.8 Million Through the Ohio Third Frontier Research and Commercialization Program 3Aegera Initiates Phase 2 Clinical Trial Of AEG33773 - A Small Molecule Targeting Neuropathic Pain 2iZumi Bio Appoints Dr. Berta Strulovici as Chief Technology Officer and Dr. Dushyant Pathak as Vice President of Business Development 2iZumi Bio Appoints Dr. Berta Strulovici as Chief Technology Officer and Dr. Dushyant Pathak as Vice President of Business Development 3
(Date:5/21/2013)... of Michigan Water Center today awarded 12 research ... restoration and protection efforts. , The two-year grants ... including efforts to track the remediation of harmful ... control non-native weedy plant invasions; study chromosomal damage ... to restoration activities. , The grants were awarded ...
(Date:5/21/2013)... decades, scientists have developed many devices that can reopen ... generally effective, each of these treatments has drawbacks, including ... from MIT analyzes the potential usefulness of a new ... drug-releasing stents, but may pose fewer risks. With this ... for only a brief period, during which it releases ...
(Date:5/20/2013)... also commonly resistant to antimicrobial substances made by ... mBio , the online open-access journal of ... and host antimicrobials LL-37 and lysozyme, which help ... that patients with life-threatening multi-drug resistant infections are ... is a last-line drug for treating several kinds ...
Breaking Biology News(10 mins):U-M Water Center awards $570K in Great Lakes restoration grants 2U-M Water Center awards $570K in Great Lakes restoration grants 3U-M Water Center awards $570K in Great Lakes restoration grants 4Evaluating a new way to open clogged arteries 2Evaluating a new way to open clogged arteries 3Resistance to last-line antibiotic makes bacteria resistant to immune system 2Resistance to last-line antibiotic makes bacteria resistant to immune system 3
... It,s commonly known, at least among microbiologists, that ... dormancy. Dormant microbes are less like zombies ... is how large numbers of dormant microorganisms affect the ... In the current issue of Nature Reviews: Microbiology ...
... common connective tissue cell in animals is the fibroblast, which ... Neta Erez of Tel Aviv University,s Sackler Faculty of Medicine ... great harm, helping to "recruit" immune cells for tumor growth. ... cancer cell proliferation is beginning, fibroblasts rush to the scene ...
... have developed a novel system for delivery of growth ... diabetic foot ulcers. In their work published in ... of Sciences , the team from the MGH Center ... keratinocyte growth factor (KGF), a protein known to play ...
Cached Biology News:The undead may influence biodiversity, greenhouse gas emissions 2Infiltrating cancer's recruitment center 2Growth-factor-containing nanoparticles accelerate healing of chronic wounds 2
2,4-Dinitrophenyl hapten is conjugated to Human Serum Albumin (HSA) protein through lysine....
PGF1α-d4 contains 4 deuterium atoms at the 3, 3', 4, and 4' positions. It is intended for use as an internal standard for the quantification of PGF1α by GC- or LC-mass spectrometry....
PGD2-d4 contains 4 deuterium atoms at the 3, 3', 4, and 4' positions. It is intended for use as an internal standard for the quantification of PGD2 by GC- or LC-mass spectrometry....
Request Info...
Biology Products: